DaVita Newsroom

TD Cowen Reaffirms Their Hold Rating on DaVita (DVA)

TipRanksJul 15 07:27 ET

DaVita (DVA) Receives a Hold From Barclays

TipRanksJul 10 05:01 ET

DaVita Analyst Ratings

BenzingaMay 15 09:44 ET

Truist Financial Keeps Their Hold Rating on DaVita (DVA)

TipRanksMay 15 07:31 ET

Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating

MT NewswiresMay 15 06:19 ET

TD Cowen Adjusts Price Target on DaVita to $139 From $136

MT NewswiresMay 7 08:04 ET

DaVita Analyst Ratings

BenzingaMay 6 11:27 ET

Barclays Adjusts Price Target on DaVita to $150 From $133

MT NewswiresMay 3 08:24 ET

Barclays Keeps Their Hold Rating on DaVita (DVA)

TipRanksApr 15 04:32 ET

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and DaVita (DVA)

TipRanksApr 3 04:06 ET

Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating

MT NewswiresMar 8 10:52 ET

DaVita Analyst Ratings

BenzingaMar 6 16:10 ET

TD Cowen Sticks to Their Hold Rating for DaVita (DVA)

TipRanksFeb 25 20:55 ET

DaVita Analyst Ratings

BenzingaFeb 20 09:16 ET

DaVita Analyst Ratings

BenzingaFeb 15 11:53 ET

UBS Adjusts DaVita Price Target to $145 From $134, Maintains Buy Rating

MT NewswiresFeb 15 11:29 ET

DaVita Analyst Ratings

BenzingaFeb 14 14:50 ET

UBS Adjusts DaVita Price Target to $134 From $113, Maintains Buy Rating

MT NewswiresFeb 14 12:29 ET

DaVita Analyst Ratings

BenzingaFeb 14 08:13 ET

Maintaining a Sell Rating on DaVita Amid Long-Term Growth Concerns and Cost Management Challenges

TipRanksFeb 14 05:45 ET